ACTREC Researchers Show Cancer Treatments May be Promoting its Spread
07.08.2025 - 18:07:50The researchers then tested whether blocking the effects of the cfChPs would change the results. As expected, the concentration of human DNA and oncoproteins in the mice's brain cells dropped significantly in mice that were treated with a cfChP-deactivating agent.
This study has important implications in reshaping cancer biology and treatment. Prof. Mittra concludes,"Future long-term experiments should explore whether cfChP-deactivating agents given concurrently with anti-cancer treatments could help prevent metastatic spread. When used as adjuncts to cancer treatment, these agents would have the added advantage of preventing some of the toxic side effects of chemotherapy and radiotherapy."
Reference
Title: Therapeutic interventions on human breast cancer xenografts promote systemic dissemination of oncogenes
Journal: PLOS One
DOI: 10.1371/journal.pone.0298042
Media contact:
Dr. Indraneel Mittra
Advance Centre for Treatment Research & Education in Cancer, Tata Memorial Centre (ACTREC)
Phone: +91 (022) 2740 5000/ 6873 5000 Extn-5136
Email: indraneel.mittra@gmail.com
Website: http://www.actrec.gov.in/pi-webpages/DrIndraneelMittra/
Photo: https://mma.prnewswire.com/media/2371768/Circulating_cell_free_chromatin.jpg
View original content:https://www.prnewswire.co.uk/news-releases/actrec-researchers-show-cancer-treatments-may-be-promoting-its-spread-302099477.html

